RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung CancersHidetoshi Sumimoto, Yataro Daigo, Atsushi Takano et al.|PLoS ONE|2016Cited by 166
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancerKoji Teramoto, Yataro Daigo, Tomoyuki Igarashi et al.|Lung Cancer|2019Cited by 59
Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitorsHidetoshi Sumimoto, Yataro Daigo, Maki Hori et al.|PLoS ONE|2024Cited by 16
Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancerKoji Teramoto, Yataro Daigo, Tomoyuki Igarashi et al.|Cancer Immunology Immunotherapy|2020Cited by 12
Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancerKoji Teramoto, Yataro Daigo, Tomoyuki Igarashi et al.|Cancer Immunology Immunotherapy|2023Cited by 11